BioSpace News Archive

Miromatrix Medical Inc., a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save patients’ lives and improve quality of life around the world, announced strategic investors involved in its Series C financing, which was followed by its June 24th IPO.

FibroGen, Inc. (NASDAQ: FGEN) today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter regarding the New Drug Application (NDA) for roxadustat for the treatment of anemia of chronic kidney disease (CKD).

- Evogene’s management provides update on its plans for unlocking the value of its subsidiaries - Conference call and webcast: today, August 11, 2021, 9:00 am ET

BD, a leading global medical technology company, announced the launch of a new benchtop cell analyzer that brings sophisticated flow cytometry capabilities to laboratories of all sizes.

Viridian Therapeutics, Inc. today announced financial results for the second quarter ended June 30, 2021, and provided corporate updates.

Stryker, one of the world’s leading medical technology companies, announced the launch of SurgiCount™+ Safety-Sponge System, its next generation surgical sponge counting technology.

Kamada Ltd today announced financial results for the three and six months ended June 30, 2021.

Imbrium Therapeutics L.P. (“Imbrium”), a subsidiary of Purdue Pharma L.P. (“Purdue”), announced today that it has exercised its option to acquire from PureTech Health PLC (“PureTech”), a worldwide exclusive license to develop, manufacture and commercialize IMB-150 (developed from PureTech’s AlivioTM technology platform and formerly designated as ALV-107), a non-opioid treatment currently being developed for interstitial cystitis/bladder pain syndrome (IC/BPS).

Imbrium Therapeutics has paid PureTech $6.5 million and PureTech is eligible to receive up to $53 million in additional development milestone payments for this program in addition to royalties on product sales

IMV Inc. today announced its financial and operational results and provided an update for the second quarter ended June 30, 2021.